← Open Payments lookup

STEPHEN DAROY: Open Payments

NPI 1740905652 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,754 in 218 payments from 17 companies in 2025. Trend: 2023 $144 · 2024 $1,647 · 2025 $3,754

Food & beverage: $3,643Education: $111
CompanyPaymentsAmount
Alkermes, Inc.29$681
Teva Pharmaceuticals USA, Inc.23$608
ABBVIE INC.35$442
Janssen Pharmaceuticals, Inc20$390
E.R. Squibb & Sons, L.L.C.32$354
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$306
Otsuka America Pharmaceutical, Inc.20$294
Neurocrine BioSciences, Inc.15$235
Bausch Health US, LLC6$104
Lundbeck LLC4$72

Products named: VRAYLAR, UZEDY, LYBALVI, COBENFY, ARISTADA, CAPLYTA, INGREZZA, SPRAVATO.

Industry payments across NJ — which companies pay providers there.